Bambusa Therapeutics, Inc. (NASDAQ:BBTX – Get Free Report) Director Ra Capital Management, L.P. acquired 453,820 shares of the stock in a transaction dated Friday, October 30th. The stock was acquired at an average price of $14.63 per share, for a total transaction of $6,639,386.60. Following the completion of the acquisition, the director directly owned 453,820 shares of the company’s stock, valued at $6,639,386.60. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Ra Capital Management, L.P. also recently made the following trade(s):
- On Monday, November 2nd, Ra Capital Management, L.P. acquired 2,500,000 shares of Bambusa Therapeutics stock. The stock was acquired at an average cost of $16.00 per share, for a total transaction of $40,000,000.00.
Bambusa Therapeutics Price Performance
BBTX remained flat at $16.00 during trading hours on Tuesday. 275,809 shares of the company traded hands, compared to its average volume of 354,454. Bambusa Therapeutics, Inc. has a fifty-two week low of $13.60 and a fifty-two week high of $17.42.
Featured Articles
- Five stocks we like better than Bambusa Therapeutics
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Bambusa Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bambusa Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
